Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2008-01-31

Clinical Trial Update: Treatment With Duloxetine for OCD Patients [NA]

View source ↗

Summary

A clinical trial evaluating duloxetine for Obsessive-Compulsive Disorder has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cymbalta (duloxetine)

Snippet

Sponsor: Sheba Medical Center | Conditions: OCD | NA | Status: WITHDRAWN